Search - tctmd.com

Displaying 1 - 20 of 219

Sort: Relevancy | Date

News Daily News

Studies Zero in on Delayed Conduction Problems After TAVI

Todd Neale

December 21, 2021

News Daily News

FDA Clears SAPIEN 3 With Alterra Prestent for Pulmonary Valve Replacement

L.A. McKeown

December 20, 2021

Presentation Controversies and Advances 2021

Recent Advances in Transcatheter Tricuspid & Mitral Valve Replacement

Presenter: Raj R. Makkar

December 03, 2021

News Opinion CV Team Dispatch

December 2021 News Roundup

L.A. McKeown

December 01, 2021

News Daily News

SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS

L.A. McKeown

November 30, 2021

News Conference News PCR London Valves 2021

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

Michael O'Riordan

November 26, 2021

News Conference News PCR London Valves 2021

MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND

Shelley Wood

November 26, 2021

News Conference News PCR London Valves 2021

‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI

Michael O'Riordan

November 25, 2021

News Conference News PCR London Valves 2021

Promising Early Results for TriClip in Tricuspid Regurgitation: bRIGHT Registry

Shelley Wood

November 24, 2021

News Daily News

US Aortic Valve Trends in Older Patients Hint at Better Outcomes, Access

L.A. McKeown

November 23, 2021

News Daily News

Even in Big Cities, There Are Barriers to TAVI Access

Caitlin E. Cox

November 17, 2021

News Conference News AHA 2021

Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years

Caitlin E. Cox

November 13, 2021

News Conference News AHA 2021

AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients

L.A. McKeown

November 13, 2021

Presentation TCT 2021

AccuCinch: Outcomes of Transcatheter LV Volume Reduction in HFrEF With a Transcatheter Ventricular Restoration System

Presenter: Ulrich Jorde

November 06, 2021

Presentation TCT 2021

Equipoise Is a Myth: NOACs Will Be Superior to LAAO

Presenter: Renato D. Lopes

November 06, 2021

Presentation TCT 2021

ICE Imaging Is Not Ready for Prime-Time: TEE Should Be the Default Approach

Presenter: Brijeshwar Maini

November 06, 2021

News Conference News TCT 2021

Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward

Yael L. Maxwell

November 06, 2021

Presentation TCT 2021

ICE Imaging Should Be the Default Approach to LAAC Procedural Imaging

Presenter: Mohamad A. Alkhouli

November 06, 2021

Presentation TCT 2021

Oral Anticoagulation Should Be the Default Strategy After LAAC

Presenter: Matthew J. Price

November 06, 2021

Presentation TCT 2021

Antiplatelet Therapy Is Sufficient for DRT Prevention After LAAC

Presenter: Jacqueline Saw

November 06, 2021

Advertisement

Studies Zero in on Delayed Conduction Problems After TAVI

FDA Clears SAPIEN 3 With Alterra Prestent for Pulmonary Valve Replacement

Recent Advances in Transcatheter Tricuspid & Mitral Valve Replacement

December 2021 News Roundup

SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND

‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI

Promising Early Results for TriClip in Tricuspid Regurgitation: bRIGHT Registry

US Aortic Valve Trends in Older Patients Hint at Better Outcomes, Access

Even in Big Cities, There Are Barriers to TAVI Access

Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years

AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients

AccuCinch: Outcomes of Transcatheter LV Volume Reduction in HFrEF With a Transcatheter Ventricular Restoration System

Equipoise Is a Myth: NOACs Will Be Superior to LAAO

ICE Imaging Is Not Ready for Prime-Time: TEE Should Be the Default Approach

Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward

ICE Imaging Should Be the Default Approach to LAAC Procedural Imaging

Oral Anticoagulation Should Be the Default Strategy After LAAC

Antiplatelet Therapy Is Sufficient for DRT Prevention After LAAC

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content